| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Generics
1 company
Gutwerg Ori is a SVP, Generics at ANI PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $6.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sell | 5,873 | $86.53 | $508,190.69 | -6.5% | +0.7% | - | |
| May 15, 2025 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sell | 881 | $60.07 | $52,921.67 | -1.0% | +49.1% | +31.0% | |
| Mar 5, 2025 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sale+OE | 5,384 | $60.00 | $323,049.00 | -2.7% | +3.3% | +26.7% | |
| Jun 5, 2024 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sell | 2,985 | $67.00 | $199,995.00 | -3.7% | -5.9% | -10.6% | |
| Aug 23, 2023 | ANIP Ani Pharmaceuticals Inc | SVP, Generics | Sale+OE | 15,561 | $62.39 | $970,850.79 | -11.2% | -18.8% | -5.1% |